Keywords: wyeth, pristiq, cleared, adults, mdd, drug, major
Wyeth's Pristiq cleared for adults with MDD
Article | 10 March 2008
US drug major Wyeth says that the Food and Drug Administration has approved Pristiq (desvenlafaxine), a structurally-novel, once-daily serotonin-norepinephrine reuptake ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Italy's pharma market slump set to continue, warns GlobalData
- Pfizer to split-off remaining 80% interest in Zoetis
